The present invention relates to formulations useful for the sustained release of antiinfectives. In particular, it relates to liposomal aminoglycoside formulation comprising an aminoglycoside, a phosphatidylcholine and a sterol. The weight ratio of the phosphatidylcholine and sterol to aminoglycoside is 2.5:1 or less.